Literature DB >> 23013361

Decreased levels of serum complement C3 and natural killer cells add to the predictive value of total immunoglobulin G for severe infection in heart transplant recipients.

E Sarmiento1, N del Pozo, A Gallego, J Fernández-Yañez, J Palomo, A Villa, M Ruiz, P Muñoz, C Rodríguez, J Rodríguez-Molina, J Navarro, K Kotsch, E Fernandez-Cruz, J Carbone.   

Abstract

BACKGROUND: Infection remains a source of mortality in heart recipients. We previously reported that post-transplant immunoglobulin G (IgG) quantification can help identify the risk for infection. We assessed whether other standardized parameters of humoral and cellular immunity could prove useful when identifying patients at risk of infection.
METHODS: We prospectively studied 133 heart recipients over a 12-month period. Forty-eight patients had at least one episode of severe infection. An event was defined as an infection requiring intravenous antimicrobial therapy.
RESULTS: Cox regression analysis revealed an association between the risk of developing infection and the following: lower IgG2 subclass levels (day 7: relative hazard [RH] 1.71; day 30: RH 1.76), lower IgA levels (day 7: RH 1.61; day 30: RH 1.91), lower complement C3 values (day 7: RH 1.25), lower CD3 absolute counts (day 30: RH 1.10), lower absolute natural killer [NK] cell count (day 7: RH 1.24), and lower IgG concentrations (day 7: RH 1.31; day 30: RH 1.36). Cox regression bivariate analysis revealed that lower day 7 C3 levels, IgG2 concentration, and absolute NK cell count remained significant after adjustment for total IgG levels.
CONCLUSIONS: Data suggest that early immune monitoring including C3, IgG2, and NK cell testing in addition to IgG concentrations is useful when attempting to identify the risk of infection in heart transplant recipients.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23013361     DOI: 10.1111/j.1399-3062.2012.00757.x

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  6 in total

1.  Intravenous immunoglobulin as an intervention strategy of risk factor modification for prevention of severe infection in heart transplantation.

Authors:  E Sarmiento; M Arraya; M Jaramillo; P Diez; J Fernandez-Yañez; J Palomo; J Navarro; J Carbone
Journal:  Clin Exp Immunol       Date:  2014-12       Impact factor: 4.330

Review 2.  Biomarker-Based Assessment for Infectious Risk Before and After Heart Transplantation.

Authors:  Athena L Huang; Nicholas Hendren; Spencer Carter; Christian Larsen; Sonia Garg; Ricardo La Hoz; Maryjane Farr
Journal:  Curr Heart Fail Rep       Date:  2022-05-21

Review 3.  Clinical immune-monitoring strategies for predicting infection risk in solid organ transplantation.

Authors:  Mario Fernández-Ruiz; Deepali Kumar; Atul Humar
Journal:  Clin Transl Immunology       Date:  2014-02-28

Review 4.  The Immunology of Posttransplant CMV Infection: Potential Effect of CMV Immunoglobulins on Distinct Components of the Immune Response to CMV.

Authors:  Javier Carbone
Journal:  Transplantation       Date:  2016-03       Impact factor: 4.939

Review 5.  The Expanding Field of Secondary Antibody Deficiency: Causes, Diagnosis, and Management.

Authors:  Smita Y Patel; Javier Carbone; Stephen Jolles
Journal:  Front Immunol       Date:  2019-02-08       Impact factor: 7.561

6.  NK and CD8+ T cell phenotypes predict onset and control of CMV viremia after kidney transplant.

Authors:  Harry Pickering; Subha Sen; Janice Arakawa-Hoyt; Kenichi Ishiyama; Yumeng Sun; Rajesh Parmar; Richard S Ahn; Gemalene Sunga; Megan Llamas; Alexander Hoffmann; Mario Deng; Suphamai Bunnapradist; Joanna M Schaenman; David W Gjertson; Maura Rossetti; Lewis L Lanier; Elaine F Reed
Journal:  JCI Insight       Date:  2021-11-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.